Thursday, February 9, 2012 Last update: 3:03 PM
The Best of U.S. Company Technology News
Now being accepted at FreshNews.com. See our complete guidelines.
CryoLife, Inc.
News articles for CryoLife, Inc.:
Thursday, February 2, 2012
- CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial ResultsATLANTA, Feb. 2, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today that 2011 fourth quarter and year end financial results will be released on Thursday, February 16, 2012. On that day, ... read more
Wednesday, January 4, 2012
- CryoLife Enhances Management Team with PromotionsATLANTA, Jan. 4, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has promoted David C. Gale, Ph.D., to the position of Vice President, Research and Development; and David P. ... read more
Monday, November 21, 2011
- CryoLife to Present at 23rd Annual Piper Jaffray Health Care ConferenceATLANTA, Nov. 21, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it will participate in the upcoming 23rd Annual Piper Jaffray Health Care Conference on Wednesday, November 30, 2011 at The New York Palace ... read more
Tuesday, November 1, 2011
- CryoLife Expands Stock Repurchase ProgramATLANTA, Nov. 1, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that its Board of Directors authorized the Company's purchase of $15 million of its common stock through December 31, 2012. The $15 million in ... read more
Monday, October 31, 2011
- CryoLife Closes $20 Million Credit Facility with GE Capital, Healthcare Financial ServicesATLANTA, Oct. 31, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced it has entered into a credit facility with GE Capital, Healthcare Financial Services for up to $20 million in revolving credit for ... read more
Thursday, October 27, 2011
- CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011ATLANTA, Oct. 27, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today its results for the third quarter and first nine months of 2011. Revenues for the third quarter increased 4 percent to a record ... read more
Monday, October 24, 2011
- CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®ATLANTA, Oct. 24, 2011 /PRNewswire/ -- CryoLife, Inc., (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, today announced that it has enrolled the first patient in its U.S. Investigational Device Exemption (IDE) clinical trial for its BioFoam® Surgical Matrix protein hydrogel technology. ... read more
Monday, October 17, 2011
- CryoLife Announces Release Date and Teleconference Call Details for 2011 Third Quarter Financial ResultsATLANTA, Oct. 17, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today that 2011 third quarter financial results will be released on Thursday, October 27, 2011. On that day, the Company will hold a teleconference ... read more
Thursday, October 13, 2011
- CryoLife Provides Update on ValveXchange®, Inc. InvestmentATLANTA, Oct. 13, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that ValveXchange, Inc., a company in which CryoLife owns a minority interest, has completed the first three human implants with its novel Vitality(TM) two-part ... read more